LUCD
Price
$1.24
Change
+$0.05 (+4.20%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
162.56M
74 days until earnings call
Intraday BUY SELL Signals
NXL
Price
$0.74
Change
+$0.06 (+8.82%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
13.71M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LUCD vs NXL

Header iconLUCD vs NXL Comparison
Open Charts LUCD vs NXLBanner chart's image
Lucid Diagnostics
Price$1.24
Change+$0.05 (+4.20%)
Volume$17.67K
Capitalization162.56M
Nexalin Technology
Price$0.74
Change+$0.06 (+8.82%)
Volume$1K
Capitalization13.71M
LUCD vs NXL Comparison Chart in %
LUCD
Daily Signal:
Gain/Loss:
NXL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LUCD vs. NXL commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUCD is a Hold and NXL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (LUCD: $1.19 vs. NXL: $0.68)
Brand notoriety: LUCD and NXL are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LUCD: 42% vs. NXL: 50%
Market capitalization -- LUCD: $156.01M vs. NXL: $12.68M
LUCD [@Medical/Nursing Services] is valued at $156.01M. NXL’s [@Medical/Nursing Services] market capitalization is $12.68M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $216.14B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LUCD’s FA Score shows that 0 FA rating(s) are green whileNXL’s FA Score has 0 green FA rating(s).

  • LUCD’s FA Score: 0 green, 5 red.
  • NXL’s FA Score: 0 green, 5 red.
According to our system of comparison, LUCD is a better buy in the long-term than NXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LUCD’s TA Score shows that 6 TA indicator(s) are bullish while NXL’s TA Score has 5 bullish TA indicator(s).

  • LUCD’s TA Score: 6 bullish, 4 bearish.
  • NXL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both LUCD and NXL are a good buy in the short-term.

Price Growth

LUCD (@Medical/Nursing Services) experienced а +5.31% price change this week, while NXL (@Medical/Nursing Services) price change was -10.81% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.18%. For the same industry, the average monthly price growth was +6.05%, and the average quarterly price growth was +19.67%.

Reported Earning Dates

LUCD is expected to report earnings on Mar 30, 2026.

NXL is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Medical/Nursing Services (+2.18% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LUCD($163M) has a higher market cap than NXL($13.7M). NXL YTD gains are higher at: 21.864 vs. LUCD (9.174). NXL has higher annual earnings (EBITDA): -8.83M vs. LUCD (-52.38M). LUCD has more cash in the bank: 47.3M vs. NXL (4.35M). NXL has less debt than LUCD: NXL (0) vs LUCD (24.3M). LUCD has higher revenues than NXL: LUCD (4.4M) vs NXL (157K).
LUCDNXLLUCD / NXL
Capitalization163M13.7M1,190%
EBITDA-52.38M-8.83M593%
Gain YTD9.17421.86442%
P/E RatioN/AN/A-
Revenue4.4M157K2,802%
Total Cash47.3M4.35M1,087%
Total Debt24.3M0-
TECHNICAL ANALYSIS
Technical Analysis
LUCDNXL
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
83%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LUCD
Daily Signal:
Gain/Loss:
NXL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALAB180.567.99
+4.63%
Astera Labs
CAPL21.410.44
+2.10%
CrossAmerica Partners LP
EDUC1.440.02
+1.41%
Educational Development Corp
QIPT3.580.03
+0.85%
Quipt Home Medical Corp
RYN23.06-0.13
-0.56%
Rayonier

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
N/A
NOTV - LUCD
32%
Poorly correlated
-3.25%
NXL - LUCD
30%
Poorly correlated
-4.24%
FEMY - LUCD
30%
Poorly correlated
-1.53%
CRL - LUCD
27%
Poorly correlated
+0.08%
INGN - LUCD
26%
Poorly correlated
+0.16%
More

NXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXL has been loosely correlated with MDAI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NXL jumps, then MDAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXL
1D Price
Change %
NXL100%
-4.24%
MDAI - NXL
34%
Loosely correlated
+0.63%
BFLY - NXL
32%
Poorly correlated
+3.04%
NNOX - NXL
31%
Poorly correlated
+1.33%
HYPR - NXL
31%
Poorly correlated
+11.76%
LUCD - NXL
30%
Poorly correlated
N/A
More